---
layout: home
title: Home
landing-title: 'Clinically vulnerable people are still shielding'
description: null
image: null
author: null
show_tile: false
---

AstraZeneca’s Evusheld is a preventative (“prophylactic”) treatment for Covid, approved for UK use on the 17th March 2022. However, there has been no progress since then on the drug’s accessibility on the NHS or privately. This has prolonged the shielding imposed on so many of us across the UK. Our group exists for one purpose: to get this drug introduced in the UK with access for all those who need it.
